| JYHB1000560 | 阿莫西林克拉维酸钾干混悬剂 | amoxicillin;potassium clavulanate | Suspension | Chemical Drugs | Supplementary Application | 2010-07-09 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Smithkline Beecham Ltd | Certificate Issued | 2011-03-24 | view |
| J0400192 | 阿莫西林克拉维酸钾干混悬剂 | amoxicillin;potassium clavulanate | Suspension | Chemical Drugs | Supplementary Application | 2004-03-08 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2004-09-10 | view |
| JYHB1600510 | 米库氯铵注射液 | mivacurium chloride | Injection | Chemical Drugs | Supplementary Application | 2016-05-10 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Manufacturing SpA | Certificate Issued | 2017-03-29 | view |
| JYHB1401055 | 米库氯铵注射液 | mivacurium chloride | Injection | Chemical Drugs | Supplementary Application | 2014-07-30 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Manufacturing SpA | Certificate Issued | 2015-02-03 | view |
| JYHB1401054 | 米库氯铵注射液 | mivacurium chloride | Injection | Chemical Drugs | Supplementary Application | 2014-07-30 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Manufacturing SpA | Certificate Issued | 2015-02-03 | view |
| JYHB1600513 | 米库氯铵注射液 | mivacurium chloride | Injection | Chemical Drugs | Supplementary Application | 2016-05-10 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Manufacturing SpA | Certificate Issued | 2017-03-29 | view |
| 25-35 | 米库氯胺注射液 | mivacurium chloride | Injection | Chemical Drugs(4) | New Drug Application | 2004-12-24 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2005-08-25 | view |
| B20020076 | 硫酸阿巴卡韦片 | abacavir sulfate | Tablet | Chemical Drugs | Import Drug Application | 2002-07-15 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Approval Completed-Pending Certificated | 2002-12-02 | view |
| AS20010003 | 白喉、破伤风、无细胞百日咳联合疫苗 | | Other | Biological Products | New Drug Application | 2001-05-22 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Approval Completed-Pending Certificated | | view |
| JYHB1100508 | 沙美特罗替卡松气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | Supplementary Application | 2011-06-09 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production | Certificate Issued | 2012-02-06 | view |
| CXLb20020005 | 沙美特罗替卡松吸入粉剂(原名：沙美特罗/丙酸氟替卡松吸入粉剂) | fluticasone propionate;salmeterol xinafoate | Inhalation | Chemical Drugs(4+5) | Supplementary Application | 2002-03-12 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2002-08-16 | view |
| JYHB1401315 | 度他雄胺软胶囊 | dutasteride | Soft capsules | Chemical Drugs | Supplementary Application | 2014-09-25 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Phaemaceuticals SA;GlaxoSmithKline (Ireland) Ltd | Certificate Issued | 2015-07-28 | view |
| JYHB1700150 | 度他雄胺软胶囊 | dutasteride | Soft capsules | Chemical Drugs | Supplementary Application | 2017-02-27 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline (Ireland) Ltd;GlaxoSmithKline Phaemaceuticals SA | Certificate Issued | 2017-06-21 | view |
| AS20020007 | 吸附无细胞百日咳,白喉,破伤风和b型流感嗜血杆菌联合疫苗 | Diphtheria,Tetanus,Acellular Pertussis and Haemophilus Influenzae Type b Combined Vaccine | Other | Biological Products | New Drug Application | 2002-04-01 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Approval Completed-Pending Certificated | 2003-09-04 | view |
| JYSB2000115 | 双价人乳头瘤病毒吸附疫苗 | Human Papillomavirus (Types 16,18) Vaccine, Adsorbed | Injection | Biological Products | Supplementary Application | 2020-04-20 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | Certificate Issued | 2020-06-23 | view |
| JYSB1900080 | 双价人乳头瘤病毒吸附疫苗 | Human Papillomavirus (Types 16,18) Vaccine, Adsorbed | Injection | Biological Products | Supplementary Application | 2019-04-15 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | Certificate Issued | 2019-09-29 | view |
| JYSB1900152 | 双价人乳头瘤病毒吸附疫苗 | Human Papillomavirus (Types 16,18) Vaccine, Adsorbed | Injection | Biological Products | Supplementary Application | 2019-07-17 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | Certificate Issued | 2020-08-31 | view |
| JYSB1900255 | 双价人乳头瘤病毒吸附疫苗 | Human Papillomavirus (Types 16,18) Vaccine, Adsorbed | Injection | Biological Products | Supplementary Application | 2019-09-18 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | Certificate Issued | 2020-09-08 | view |
| JXSS2100017 | 双价人乳头瘤病毒吸附疫苗 | Human Papillomavirus (Types 16,18) Vaccine, Adsorbed | Injection | Biological Products(3.1) | Import Drug Application | 2021-02-25 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | In Review | 2021-02-24 | view |
| JYSB1900148 | 双价人乳头瘤病毒吸附疫苗 | Human Papillomavirus (Types 16,18) Vaccine, Adsorbed | Injection | Biological Products | Supplementary Application | 2019-07-17 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | Certificate Issued | 2020-06-10 | view |
